tci Medicare Compliance & Reimbursement - 2005 Issue 28
MEDICAID: Reps Rail Against Medicaid Drug System
Subscribe or sign in to view the full article.
Article Overview
This article summarizes a congressional hearing on Medicaid prescription drug payment reform and the concerns raised by U.S. representatives about how the program determines drug payments. It discusses broader issues involving generic drugs, average wholesale price-based reimbursement, and reported spending anomalies. The piece is relevant for readers following Medicaid policy, pharmacy reimbursement, and federal oversight of drug pricing methods.
Why This Topic Matters
It helps readers understand why Medicaid drug payment methodology drew congressional scrutiny and why reimbursement benchmarks were being questioned. The article is useful for stakeholders in Medicaid policy, pharmacy reimbursement, and legislative oversight who need a high-level view of the reform debate.
What You Will Learn
- What prompted congressional scrutiny of Medicaid drug payment practices
- Why average wholesale price-based reimbursement drew criticism
- How generic drug pricing trends were discussed in relation to Medicaid spending
- Which legislative and oversight concerns were raised during the hearing
Who Should Read This
- Medical coders
- Billing and reimbursement professionals
- Pharmacy reimbursement analysts
- Medicaid policy staff
- Healthcare compliance professionals
- Health policy researchers
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com